10 self-costed drugs online procurement qualifications were suspended!

Shanghai's strengthening of the management of self-funded drugs began in 2017, in accordance with the "Notice on further strengthening the city's medical insurance fixed-point medical institutions self-funded drug procurement and use management" (Shanghai People's Social Medicine (2017) No. 263), the main purpose is to "eliminate commercial bribery violations, effectively reduce the city's self-funded drugs "falsely high" prices, reduce unnecessary self-funded drug procurement and use, promote clinical rational drug use, and further reduce the burden of self-funded drugs.
Since 2017, Shanghai has fully implemented the "variety directly linked to the net, price agreed transaction" of the self-financing drugs purchased through the sun platform, that is, pharmaceutical production enterprises (or entrusted enterprises, the same between) take the initiative to provide the sun platform with basic information on drugs and price information in other provinces and cities, medical institutions must and production enterprises through the sun platform to determine the transaction price, and the transaction price in the sunshine platform after the public procurement.
transaction price shall not be higher than the purchase price of the same variety in Beijing, Tianjin, Zhejiang, Jiangsu, Guangdong and other provincial drug procurement platforms.
shanghai stopped thousands of varieties in 2017, mainly undeclared, non-bargained and history-free.
is the reason for the 10 varieties that have been suspended this time? In accordance with the relevant provisions of Shanghai self-funded drug strengthening management, pharmaceutical production enterprises should take the initiative to provide basic information on self-funded drugs and price information in foreign provinces and cities, and regularly update according to the provisions, if there is an misstal, understring, after verification within 1 year suspended the qualification of the network involving drugs, with the enterprise within 1 year cumulative occurrence of more than 3 times (including), within 1 year suspended all self-funded drugs hanging network qualification.
▌ Shanghai clinical self-cost drug use requirements In accordance with the relevant documents, Shanghai clinical self-cost drug use also has corresponding requirements, as follows: 1. Medical institutions and physicians may not induce or force patients to use out-of-the-cost drugs.
the use of out-of-the-box medicines due to clinical needs, the written notification system shall be strictly implemented and may be used only with the signature and consent of the patient or his client.
. Medical institutions and physicians may not induce or compel patients to purchase out-of-hospital medicines at their own expense.
clinically necessary, medical institutions must be equipped to ensure safe and rational drug use.
medical institutions should establish a sound approval or filing system for out-of-hospital purchases of out-of-hospital drugs for individual patients with very small numbers and very little use.
3. Physicians who issue self-funded medicines to patients, whether purchased in or out of hospital, shall improve the records of the use of out-patient, in-patient medical records and self-funded medicines in electronic medical records in accordance with the relevant requirements of the Basic Standards for the Writing of Medical Records and the Regulations for the Application of Electronic Medical Records (Trial).
4. Medical institutions shall incorporate the self-funded medicines used by patients for medical treatment into the internal management of hospitals, issue corresponding bills for all medical expenses submitted by patients, and shall be managed in accordance with the relevant financial regulations, and the amount of out-of-the-money medical expenses shall be fully included in the cash payment column, and the relevant departments such as medical insurance and health planning shall be uploaded truthfully in accordance with the provisions.
Attached to today's notice: Notice on the suspension of the procurement qualification of part of the self-funded drug network Shanghai Pharmaceuticals (2020) No. 70 medical institutions, pharmaceutical production enterprises: According to the "Notice on further strengthening the city's medical insurance fixed-point medical institutions self-funded drug procurement and use management notice" (Shanghai People's Social Medicine (20) 17) No. 263) and the "Notice on further improving the procurement of self-costed drugs in this city" (Shanghai Pharmaceuticals (2017) No. 29) provisions, suspended part of the non-compliant with the relevant provisions of the self-expensed drug network of drugs online procurement qualifications for one year, see the annex.
this notice will take effect from 22 September 2020.
Shanghai Pharmaceutical Central Tendering and Procurement Management Institute september 16, 2020.